Log in
Enquire now
‌

US Patent 10947544 Aptamer therapeutics useful in the treatment of complement-related disorders

Patent 10947544 was granted and assigned to Archemix on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Archemix
Archemix
Current Assignee
Archemix
Archemix
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10947544
Date of Patent
March 16, 2021
Patent Application Number
16289374
Date Filed
February 28, 2019
Patent Citations
‌
US Patent 10308943 Compositions with improved intravitreal half-life and uses thereof
Patent Primary Examiner
‌
Brian Whiteman
Patent abstract

The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10947544 Aptamer therapeutics useful in the treatment of complement-related disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us